Directions in Research
Presented by Michael Dellinger, PhD, University of Texas Southwestern Medical Center
In the past, there were limited resources available for research on generalized lymphatic anomaly (GLA), kaposiform lymphangiomatosis (KLA), and Gorham-Stout disease (GSD). The Lymphatic Malformation Institute (LMI) was created in 2011 to address this need. The LMI fosters collaborations among scientists and promotes the dissemination of knowledge on GLA, KLA, and GSD. Additionally, the LMI funds research on these rare diseases. Since 2011, the LMI has invested over 3.5 million dollars in basic science, preclinical, and clinical research on GLA, KLA, and GSD. This research has yielded valuable insight into the biology of lymphatic anomalies. In my presentation, I will discuss the latest advances in research on GLA, KLA, and GSD.
About the Presenter
Dr. Dellinger is an Assistant Professor in the Department of Surgery at UT Southwestern Medical Center and his lab studies Gorham-Stout disease, generalized lymphatic anomaly, and kaposiform lymphangiomatosis. Dr. Dellinger serves as the Director of Research for the Lymphatic Malformation Institute (LMI) where he provides scientific leadership to the program. He is responsible for identifying research avenues relevant for investigation and ensuring that projects meet a high level of scientific standard.